Top Markets
Coin of the day
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQS
Rang in Aktien #39477
Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company... Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company dedicated to advancing and commercializing therapeutic solutions. Its core operations span critical areas such as neurology, ophthalmology, and transplantation. The company currently markets a range of products, including Vistitan, an ophthalmic treatment designed to alleviate elevated intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. Another key offering is Tacrolimus IR, an immunosuppressant vital for both preventing and treating acute rejection in organ transplant recipients. Aequus also provides its Evolve line of dry eye products, which target various symptoms associated with dry eye disease and blepharitis, such as discomfort, stinging, burning, and dryness, alongside a preservative-free ophthalmic option. In its development pipeline, Aequus is progressing several innovative candidates. These include Topiramate XR and Oxcarbazepine XR, extended-release oral tablets aimed at epilepsy treatment; AQS1303, a transdermal formulation of pyridoxine/doxylamine developed to combat nausea and vomiting during pregnancy; and AQS1304, a cannabinoid-based therapeutic under investigation for neurological disorders. To support its market reach and innovation, Aequus has forged strategic alliances. These include an agreement with Sandoz Canada, Inc. for the promotion of Vistitan; a partnership with Supernus Pharmaceuticals, Inc. for the marketing of its extended-release anti-epileptic drugs; and a collaboration with Medicom Healthcare Ltd. centered on preservative-free ophthalmic treatments. Established in 2013, Aequus Pharmaceuticals Inc. maintains its corporate headquarters in Vancouver, Canada.
Aktienkurs
$0.00359455
Zuletzt synchronisiert: 2025-05-20
Marktkapitalisierung
$476.76K
Veränderung (1 Tag)
0.44%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Aequus Pharmaceuticals Inc. (AQS)

Kategorie

Kursverlauf für Aequus Pharmaceuticals Inc. (AQS)
Höchster Schlusskurs: $0.00 am 2025-05-01

Niedrigster Schlusskurs: $0.55 am 2015-03-01
Kursverlauf der Aktie von Aequus Pharmaceuticals Inc. von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -2.36%
2024 -82.41%
2023 -5.81%
2022 -74.31%
2021 7.28%
2020 -22.02%
2019 -13.02%
2018 -32.54%
2017 -8.75%
2016 -57.19%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$162.62 25.81%
DE
$36.61 23.93%
JP
$228.31 40.75%
CH
$21.30 13.79%
IN